127 related articles for article (PubMed ID: 11125022)
1. Increased stability of nucleophosmin/B23 in anti-apoptotic effect of ras during serum deprivation.
Chou CC; Yung BY
Mol Pharmacol; 2001 Jan; 59(1):38-45. PubMed ID: 11125022
[TBL] [Abstract][Full Text] [Related]
2. Mortalization of human promyelocytic leukemia HL-60 cells to be more susceptible to sodium butyrate-induced apoptosis and inhibition of telomerase activity by down-regulation of nucleophosmin/B23.
Liu WH; Yung BY
Oncogene; 1998 Dec; 17(23):3055-64. PubMed ID: 9881708
[TBL] [Abstract][Full Text] [Related]
3. Involvement of nucleophosmin/B23 in the response of HeLa cells to UV irradiation.
Wu MH; Chang JH; Chou CC; Yung BY
Int J Cancer; 2002 Jan; 97(3):297-305. PubMed ID: 11774280
[TBL] [Abstract][Full Text] [Related]
4. Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression.
Wu MH; Chang JH; Yung BY
Carcinogenesis; 2002 Jan; 23(1):93-100. PubMed ID: 11756229
[TBL] [Abstract][Full Text] [Related]
5. Ras-dependent recruitment of c-Myc for transcriptional activation of nucleophosmin/B23 in highly malignant U1 bladder cancer cells.
Yeh CW; Huang SS; Lee RP; Yung BY
Mol Pharmacol; 2006 Oct; 70(4):1443-53. PubMed ID: 16857742
[TBL] [Abstract][Full Text] [Related]
6. Involvement of nucleophosmin/B23 in the cellular response to curcumin.
Weng CH; Yung BY; Weng JJ; Wu MH
J Nutr Biochem; 2011 Jan; 22(1):46-52. PubMed ID: 20303727
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells.
Hsu CY; Yung BY
Oncogene; 1998 Feb; 16(7):915-23. PubMed ID: 9484783
[TBL] [Abstract][Full Text] [Related]
8. Nucleophosmin/B23 regulates the susceptibility of human leukemia HL-60 cells to sodium butyrate-induced apoptosis and inhibition of telomerase activity.
Liu WH; Hsu CY; Yung BY
Int J Cancer; 1999 Dec; 83(6):765-71. PubMed ID: 10597193
[TBL] [Abstract][Full Text] [Related]
9. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity.
Wu HL; Hsu CY; Liu WH; Yung BY
Int J Cancer; 1999 Jun; 81(6):923-9. PubMed ID: 10362140
[TBL] [Abstract][Full Text] [Related]
10. c-Myc-mediated expression of nucleophosmin/B23 decreases during retinoic acid-induced differentiation of human leukemia HL-60 cells.
Yung BY
FEBS Lett; 2004 Dec; 578(3):211-6. PubMed ID: 15589822
[TBL] [Abstract][Full Text] [Related]
11. Antiapoptotic effect of ras in the apoptosis induced by serum deprivation and exposure to actinomycin D.
Chou CC; Yung BY
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):177-82. PubMed ID: 9050009
[TBL] [Abstract][Full Text] [Related]
12. Decrease in nucleophosmin/B23 mRNA and telomerase activity during indomethacin-induced apoptosis of gastric KATO-III cancer cells.
You BJ; Huang IJ; Liu WH; Hung YB; Chang JH; Yung BY
Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):683-90. PubMed ID: 10619186
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis.
Hsu CY; Yung BY
Int J Cancer; 2000 Nov; 88(3):392-400. PubMed ID: 11054668
[TBL] [Abstract][Full Text] [Related]
14. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB.
Lin CY; Liang YC; Yung BY
Cell Signal; 2006 Nov; 18(11):2041-8. PubMed ID: 16725311
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23.
Takemura M; Ohoka F; Perpelescu M; Ogawa M; Matsushita H; Takaba T; Akiyama T; Umekawa H; Furuichi Y; Cook PR; Yoshida S
Exp Cell Res; 2002 Jun; 276(2):233-41. PubMed ID: 12027453
[TBL] [Abstract][Full Text] [Related]
16. In vivo interaction of nucleophosmin/B23 and protein C23 during cell cycle progression in HeLa cells.
Liu HT; Yung BY
Cancer Lett; 1999 Sep; 144(1):45-54. PubMed ID: 10503877
[TBL] [Abstract][Full Text] [Related]
17. Nucleophosmin/B23-binding peptide inhibits tumor growth and up-regulates transcriptional activity of p53.
Chan HJ; Weng JJ; Yung BY
Biochem Biophys Res Commun; 2005 Jul; 333(2):396-403. PubMed ID: 15950182
[TBL] [Abstract][Full Text] [Related]
18. Disruption of ATP binding destabilizes NPM/B23 and inhibits anti-apoptotic function.
Choi JW; Lee SB; Ahn JY; Lee KH
BMB Rep; 2008 Dec; 41(12):840-5. PubMed ID: 19123973
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Ras-induced cancers by the F-actin cappers tensin and chaetoglobosin K, in combination with the caspase-1 inhibitor N1445.
Tikoo A; Cutler H; Lo SH; Chen LB; Maruta H
Cancer J Sci Am; 1999; 5(5):293-300. PubMed ID: 10526670
[TBL] [Abstract][Full Text] [Related]
20. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
